{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T16:48:00Z","timestamp":1793810880764,"version":"4.6.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Allogeneic graft rejection is the leading cause of graft failure in corneal transplantation (CT) despite the immune privilege of the anterior chamber and corneal bed. The ability to identify patients at higher risk of acute rejection before or after CT could have a major impact on the clinical management of these patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>To address this important issue, a multicenter European cohort of low-risk (n\u2005=\u2005142) and high-risk (n\u2005=\u2005102) CT recipients was established, and the immune system was evaluated in detail in peripheral blood mononuclear cells and plasma before and 6 and 12 mo posttransplantation. Eleven patients in the low-risk group and 11 in the high-risk group experienced acute rejection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Mass spectrometry analysis of plasma showed a high similarity in composition between patients with and without acute rejection, regardless of their preexisting clinical risk. Pretransplant and longitudinal immune cell analysis of peripheral blood mononuclear cells using deconvolution of transcriptomic profiling and high-dimensional flow cytometry revealed a lack of immune-related biomarkers associated with acute rejection.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Our results indicate that the immune response leading to acute rejection of CT is unlikely to be detected in the peripheral blood and suggest that analysis of compartments in close proximity to the cornea is more likely to yield clinically applicable predictive biomarkers.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005280","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:59Z","timestamp":1733961659000},"page":"794-805","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Corneal Graft Rejection: Is It Reflected in Peripheral Immune Cells? Results of a Prospective Multicenter Study (VISICORT)"],"prefix":"10.1097","volume":"109","author":[{"given":"Bertrand","family":"Vabres","sequence":"first","affiliation":[{"name":"Nantes Universit\u00e9, CHU Nantes, Service Ophtalmologie, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Charit\u00e9 University Hospital, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Hjortdal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark."},{"name":"Department of Clinical Medicine, Aarhus University, Aarhus, Denmark."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor C.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Royal Victoria Eye and Ear Hospital, Dublin, Ireland."},{"name":"Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. John","family":"Armitage","sequence":"additional","affiliation":[{"name":"Translational Health Sciences, University of Bristol, Bristol, United Kingdom."},{"name":"Tissue and Eye Services, NHS Blood and Transplant, Bristol, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Imrie","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Cadoux","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France."},{"name":"CHU Nantes, Institut De Transplantation Urologie N\u00e9phrologie (ITUN), Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Danger","sequence":"additional","affiliation":[{"name":"Royal College of Surgeons in Ireland University of Medicine and Health Sciences, Dublin, Ireland."},{"name":"Translational Health Sciences, University of Bristol, Bristol, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Bylesjo","sequence":"additional","affiliation":[{"name":"Fios Genomics Ltd, Nine Edinburgh Bioquarter, Edinburgh, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peadar","family":"Mac Gabhann","sequence":"additional","affiliation":[{"name":"Biost\u00f3r Ireland, Rosslare, Co, Wexford, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Tole","sequence":"additional","affiliation":[{"name":"University Hospitals Bristol NHS Foundations Trust, Bristol Eye Hospital, Bristol, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm D.","family":"Walkinshaw","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Cell Biology, School of Biological Sciences, University of Edinburgh, Edinburgh, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Regenerative Medicine Institute (REMEDI) at C\u00daRAM SFI Research Centre for Medical Devices, School of Medicine, University of Galway, Galway, Ireland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Brouard","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France."},{"name":"CHU Nantes, Institut De Transplantation Urologie N\u00e9phrologie (ITUN), Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Degauque","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, INSERM, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France."},{"name":"CHU Nantes, Institut De Transplantation Urologie N\u00e9phrologie (ITUN), Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"key":"R1-20250714","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/ceo.14089","article-title":"Outcomes of corneal transplantation in Australia, in an era of lamellar keratoplasty.","volume":"50","author":"Williams","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"key":"R2-20250714","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1097\/TP.0000000000002938","article-title":"High-risk corneal transplantation: recent developments and future possibilities.","volume":"103","author":"Armitage","year":"2019","journal-title":"Transplantation"},{"key":"R3-20250714","first-page":"CD007603","article-title":"Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty.","volume":"2015","author":"Abudou","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R4-20250714","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/ICO.0000000000000403","article-title":"Prevention and treatment of corneal graft rejection.","volume":"34","author":"Kharod-Dholakia","year":"2015","journal-title":"Cornea"},{"key":"R5-20250714","doi-asserted-by":"crossref","first-page":"100768","DOI":"10.1016\/j.preteyeres.2019.07.001","article-title":"Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation.","volume":"73","author":"Hos","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"R6-20250714","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/TP.0000000000000512","article-title":"VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation.","volume":"99","author":"Dohlman","year":"2015","journal-title":"Transplantation"},{"key":"R7-20250714","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/ajt.15331","article-title":"Local VEGF-A blockade modulates the microenvironment of the corneal graft bed.","volume":"19","author":"Salabarria","year":"2019","journal-title":"Am J Transplant"},{"key":"R8-20250714","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/ajt.16824","article-title":"Pre-incubation of corneal donor tissue with sCD83 improves graft survival via the induction of alternatively activated macrophages and tolerogenic dendritic cells.","volume":"22","author":"Peckert-Maier","year":"2022","journal-title":"Am J Transplant"},{"key":"R9-20250714","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1111\/ajt.17119","article-title":"Peripheral blood immune cell profiling of acute corneal transplant rejection.","volume":"22","author":"Hjortdal","year":"2022","journal-title":"Am J Transplant"},{"key":"R10-20250714","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry.","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"key":"R11-20250714","first-page":"1","article-title":"Helios is a marker, not a driver, of human Treg stability.","volume":"0","author":"Lam","year":"2021","journal-title":"Eur J Immunol"},{"key":"R12-20250714","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/j.1600-6143.2008.02285.x","article-title":"Aqueous humor alloreactive cell phenotypes, cytokines and chemokines in corneal allograft rejection.","volume":"8","author":"Flynn","year":"2008","journal-title":"Am J Transplant"},{"key":"R13-20250714","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.1992.01080220054021","article-title":"The collaborative corneal transplantation studies (CCTS): effectiveness of histocompatibility matching in high-risk corneal transplantation.","volume":"110","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R14-20250714","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bjophthalmol-2020-317543","article-title":"Corneal transplant follow-up study II: a randomised trial to determine whether HLA class II matching reduces the risk of allograft rejection in penetrating keratoplasty.","volume":"106","author":"Armitage","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R15-20250714","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00417-003-0759-9","article-title":"HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection.","volume":"241","author":"Khaireddin","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R16-20250714","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00007890-199704150-00018","article-title":"Association between HLA-DPB1 matching and 1-year rejection free graft survival in high risk corneal transplantation.","volume":"63","author":"Batmunkh","year":"1997","journal-title":"Transplantation"},{"key":"R17-20250714","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM198607033150105","article-title":"Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation.","volume":"315","author":"Sanfilippo","year":"1986","journal-title":"N Engl J Med"},{"key":"R18-20250714","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF00171668","article-title":"Circulating cornea-specific antibodies in corneal disease and cornea transplantation.","volume":"232","author":"Jager","year":"1994","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R19-20250714","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00003226-200308000-00013","article-title":"Long-term outcome in high-risk corneal transplantation and the influence of HLA-A and HLA-B matching.","volume":"22","author":"Bartels","year":"2003","journal-title":"Cornea"},{"key":"R20-20250714","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00007890-199209000-00015","article-title":"Pretransplant and posttransplant antibodies in human corneal transplantation.","volume":"54","author":"Roy","year":"1992","journal-title":"Transplantation"},{"key":"R21-20250714","first-page":"250","article-title":"Corneal transplantation in antibody-deficient hosts.","volume":"40","author":"Goslings","year":"1999","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"R22-20250714","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1056\/NEJMra2014530","article-title":"Long-term survival after kidney transplantation.","volume":"385","author":"Hariharan","year":"2021","journal-title":"N Engl J Med"},{"key":"R23-20250714","first-page":"1016","article-title":"Predicting the risk for corneal graft rejection by aqueous humor analysis.","volume":"17","author":"Maier","year":"2011","journal-title":"Mol Vis"},{"key":"R24-20250714","first-page":"613","article-title":"Elevation of preoperative recipient aqueous cytokine levels in eyes with primary graft failure after corneal transplantation.","volume":"24","author":"Yamaguchi","year":"2018","journal-title":"Mol Vis"},{"key":"R25-20250714","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/jcm9020586","article-title":"Variable responses to corneal grafts: insights from immunology and systems biology.","volume":"9","author":"Di Zazzo","year":"2020","journal-title":"J Clin Med"},{"key":"R26-20250714","article-title":"Blood gene signature as a biomarker for subclinical kidney allograft rejection: where are we?","author":"Masset","journal-title":"Transplantation"},{"key":"R27-20250714","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1097\/TP.0000000000004542","article-title":"Contribution of proteomics in transplantation: identification of injury and rejection markers.","volume":"107","author":"Zubair","year":"2023","journal-title":"Transplantation"},{"key":"R28-20250714","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/TP.0000000000004946","article-title":"Serum extracellular vesicle protein profiling for prediction of corneal transplant rejection.","volume":"108","author":"Lee","year":"2024","journal-title":"Transplantation"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T20:01:03Z","timestamp":1752523263000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005280","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]}}}